Mitoxantrone: a review of its use in multiple sclerosis.
about
Evaluating the Role of Corticosteroid Pulse Therapy in Patients With Secondary Progressive Multiple Sclerosis Receiving Mitoxantrone: A Double Blind Randomized Controlled Clinical Trial.Asymmetric enzymatic glycosylation of mitoxantroneManagement of optic neuritisEffects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon β-1α: A randomized controlled trialAntigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding.The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancyThe cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?Quality of life in multiple sclerosis: effects of current treatment options.High-dose chemotherapy and multiple sclerosis.Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence.Recent biotechnological progress in enzymatic synthesis of glycosides.Advancing drug delivery systems for the treatment of multiple sclerosis.Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives.Catalytic asymmetric reactions and synthesis of quinones.Dying to protect: cell death and the control of T-cell homeostasis.Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy.Efficacy and safety of mitoxantrone use in primary and secondary progressive multiple sclerosis - study site experience based on the therapy of 104 patients.Antibodies against CD20 (rituximab) for treating multiple sclerosis: US20100233121.Drugs approved for the treatment of multiple sclerosis: review of their safety profile.Binding mechanism of anti-cancer chemotherapeutic drug mitoxantrone to DNA characterized by magnetic tweezers.
P2860
Q31023281-B5785F45-6D97-4D98-8DD7-6FD90FF3771FQ34996995-AD9C8EBA-E5BB-4BB7-B41B-526BCA8C0270Q35049583-44B16651-B5EB-4526-9840-672E74D357BBQ35544804-844050D2-E001-4CFA-8545-70783B7D53BFQ35637379-213C7D1D-8121-4920-AD1E-FB341DBC531BQ35888381-EF150480-8F0C-419A-8D4F-EEA63D42B09DQ36062456-4CED0BA4-99E6-4373-BA0E-7486FF906FAAQ36298897-7CD26B21-BDDA-41DF-9833-80821FEC7655Q36407273-B21C1E23-1859-4A99-AD19-E65D8736F4D8Q37710122-7E0F2EFC-5E68-4DAD-B9F0-B1A2349116D1Q37822255-722D20D9-B421-46ED-A505-8899010458E1Q37976344-AE03223C-FCD2-4885-B08E-679812FBAC29Q38134321-C87063A2-02E9-4A04-860C-FE70936F9FD4Q38609620-64A3378C-58CC-430B-8E1C-68876F1B7576Q38643129-C9326E4D-3ED9-4775-9B93-DF8712813A79Q38874469-C3CE1E1B-923D-418C-8A11-C390B6CE5E17Q39277476-B0C8D5AA-67DB-4B4B-97D1-98FCCDEE75F9Q39482884-36601907-F545-4BF4-91D7-7F9A05231F1BQ40423250-327C46BB-DD50-40EB-8736-2A841728D74FQ45865616-2EFF4824-F1B4-44DF-887E-2F94DEE553A1Q47868767-04DBE3D4-BE2C-4697-AF18-B81F07D8670AQ55633988-98A58F32-F109-43D8-9AC7-26E3751FCF32
P2860
Mitoxantrone: a review of its use in multiple sclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Mitoxantrone: a review of its use in multiple sclerosis.
@ast
Mitoxantrone: a review of its use in multiple sclerosis.
@en
type
label
Mitoxantrone: a review of its use in multiple sclerosis.
@ast
Mitoxantrone: a review of its use in multiple sclerosis.
@en
prefLabel
Mitoxantrone: a review of its use in multiple sclerosis.
@ast
Mitoxantrone: a review of its use in multiple sclerosis.
@en
P2860
P1433
P1476
Mitoxantrone: a review of its use in multiple sclerosis.
@en
P2860
P304
P356
10.2165/00023210-200418060-00010
P577
2004-01-01T00:00:00Z
P6179
1006602268